Your browser doesn't support javascript.
loading
Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.
Pfeiffer, Kathryn M; Brod, Meryl; Smith, Alden; Gianettoni, Jill; Viuff, Dorthe; Ota, Sho; Charlton, R Will.
Affiliation
  • Pfeiffer KM; Health Outcomes Research, The Brod Group, California, USA.
  • Brod M; Health Outcomes Research, The Brod Group, California, USA.
  • Smith A; Market Access, Ascendis Pharma, Inc., Palo Alto, California, USA.
  • Gianettoni J; Clinical Operations, Ascendis Pharma, Inc., Palo Alto, California, USA.
  • Viuff D; Strategy & Project Management, Ascendis Pharma, A/S, Hellerup, Denmark.
  • Ota S; Clinical Development, Ascendis Pharma, Inc., Palo Alto, California, USA.
  • Charlton RW; Clinical Development, Ascendis Pharma, Inc., Palo Alto, California, USA.
Am J Med Genet A ; 185(1): 33-45, 2021 01.
Article de En | MEDLINE | ID: mdl-33084192
ABSTRACT
This study's purpose was to provide qualitative evidence to support the development of two observer-reported outcome measures assessing the physical symptoms/complications of achondroplasia in children and impacts on children's quality of life. Individual/focus group concept elicitation interviews were conducted with parents of children aged 2 to <12 years with achondroplasia and experts. Qualitative analysis of transcripts, based on an adapted grounded theory approach, informed item generation and measure development. Cognitive debriefing (CD) interviews were conducted with parents to confirm relevance and understanding. Thirty-six parents participated in concept elicitation interviews. The analysis identified major physical symptoms/complications and impacts of achondroplasia, which informed the development of the Achondroplasia Child Experience Measures (ACEMs) ACEM-Symptom and ACEM-Impact. ACEM-Symptom was comprised of eight major symptoms/complications including pain (58%), ear infections/fluid in ear (56%), and low stamina/tiring easily (56%). ACEM-Impact consisted of 31 major impacts in the domains of daily functioning, emotional well-being, social well-being, and need for assistance/adaptive devices. Impacts on functioning included difficulty reaching objects/high places (89%) and toileting (67%). Emotional impacts included feeling different (53%) and feeling frustrated/annoyed (47%). Social impacts included difficulty participating in sports/physical play (86%) and being treated as younger than age (83%). Following CD interviews with 16 additional parents, validation-ready ACEM measures were generated. The study improves our understanding of the experiences of children with achondroplasia and provides evidence supporting the content validity of the ACEMs. Validated ACEMs may be used to assess potential benefits of future treatments for comorbidities of achondroplasia.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psychométrie / Achondroplasie / Émotions Type d'étude: Diagnostic_studies / Qualitative_research Aspects: Patient_preference Limites: Adolescent / Child / Child, preschool / Female / Humans / Male Langue: En Journal: Am J Med Genet A Sujet du journal: GENETICA MEDICA Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psychométrie / Achondroplasie / Émotions Type d'étude: Diagnostic_studies / Qualitative_research Aspects: Patient_preference Limites: Adolescent / Child / Child, preschool / Female / Humans / Male Langue: En Journal: Am J Med Genet A Sujet du journal: GENETICA MEDICA Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
...